This research will be conducted to determine whether risk factors exist for piperacillin/tazobactam resistance in ESBL organisms.
This is chart review at UPMC. NO human subject interaction will occur.
Study Type
OBSERVATIONAL
Enrollment
450
UPMC
Pittsburgh, Pennsylvania, United States
This research will help to identify risk factors for resistance to an antibiotic that is commonly used in the empiric treatment of critically ill patients.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.